Market Overview

Aegis Capital Initiates Coverage on TrovaGene, Inc. at Buy, Announces $12.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for TROV

DateFirmActionFromTo
Apr 2016Leerink SwannDowngradesOutperformSector Perform
Apr 2016Cantor FitzgeraldDowngradesBuyHold
Apr 2016Cantor FitzgeraldDowngradesBuyHold

View More Analyst Ratings for TROV
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (TROV)